✦ LIBER ✦

23. Pharmacological chaperone treatment for Pompe disease

✍ Scribed by Hung Do; John Flanagan; Xiaoyang Wu; Allan Powe; Richie Khana; Rebecca Soska; Wei Liang; Elfrida Benjamin; David Palling; Sheela Sitaraman; Brandon Wustman; Ken Valenzano; David Lockhart

Book ID: 116988208
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 42 KB
Volume: 93
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2007.10.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

G.O. 7 Pharmacological chaperones as an

G.O. 7 Pharmacological chaperones as an alternate treatment for Pompe disease

✍ B.A. Wustman; R. Khanna; A.C. Powe Jr.; R. Dhulipala; E. Benjamin; C.W. Pine; W. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Pharmacological chaperones: potential tr

Pharmacological chaperones: potential treatment for conformational diseases

✍ Virginie Bernier; Monique Lagacé; Daniel G Bichet; Michel Bouvier 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 550 KB

Screening for pharmacological chaperones

Screening for pharmacological chaperones in Fabry disease

✍ Sang-Hoon Shin; Gary J. Murray; Stefanie Kluepfel-Stahl; Adele M. Cooney; Jane M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 176 KB

M.P.5.09 Pharmacological chaperone thera

M.P.5.09 Pharmacological chaperone therapy for the treatment of Pompe disease: Deoxynojirimycin increases lysosomal levels and specific activity of acid alpha-glucosidase

✍ B. Wustman; A. Powe Jr.; J. Flanagan; R. Khanna; W. Liang; X. Wu; R. Dhulipala; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

50. The pharmacological chaperone AT1001

50. The pharmacological chaperone AT1001 and treatment of Fabry disease

✍ Richie Khanna; Elfrida R. Benjamin; Rebecca Soska; Yi Lun; Sheela A. Sitaraman; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 42 KB

63. Pharmacological chaperone treatment

63. Pharmacological chaperone treatment for lysosomal storage disorders

✍ David Lockhart 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 43 KB